Research Study

An Open-Label Phase 3b Study to Assess Mucosal Healing in Subjects With Moderately to Severely Active Crohn's Disease Treated With Vedolizumab IV
Principal Investigator 
Baljinder Salh

Overview

Body Locations and Systems 
Crohn's Disease
ClinicalTrials.gov# 
NCT02425111
Status 
Recruiting
Study Start/End 
Feb 4, 2016 to Aug 9, 2017
Locations 
Diamond Health Care Centre, Vancouver General Hospital
Name/Title 
Jo-Ann Ford, Research Coordinator
Phone 
604-875-5705
Email Address 
joann.ford@vch.ca
Purpose of Study 

The purpose of this study is to evaluate endoscopic remission at Week 26 as assessed by ileocolonoscopy.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.